Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Molecular & Cellular Oncology|June 17, 2016
Untargeted metabolomics for profiling oncogene-specific metabolic signatures of prostate cancerCarmen Priolo, Massimo Loda
Molecular Cancer Research : MCR|October 10, 2014
Therapeutic targeting of cellular metabolism in cells with hyperactive mTORC1: a paradigm shiftDoug Medvetz, Carmen Priolo, Elizabeth P Henske
Idrugs : the Investigational Drugs Journal|April 1, 2009
Novel therapeutic strategies in prostate cancer: establishing a stratification system for patient selection in targeted trialsCarmen Priolo, William K Oh, Massimo Loda
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2010
New strategies in prostate cancer: targeting lipogenic pathways and the energy sensor AMPKGiorgia Zadra, Carmen Priolo, Akash Patnaik, et al.
Circulation Research|April 23, 2021
Immunometabolic Endothelial Phenotypes: Integrating Inflammation and Glucose MetabolismWusheng Xiao, William M Oldham, Carmen Priolo, et al.
Plos One|April 5, 2013
MicroRNA-21 is induced by rapamycin in a model of tuberous sclerosis (TSC) and lymphangioleiomyomatosis (LAM)Anil J Trindade, Douglas A Medvetz, Nicole A Neuman, et al.
American Journal of Respiratory Cell and Molecular Biology|March 18, 2015
Tuberous sclerosis complex 2 loss increases lysophosphatidylcholine synthesis in lymphangioleiomyomatosisCarmen Priolo, Stéphane J H Ricoult, Damir Khabibullin, et al.
Cancer Research|May 13, 2020
Therapeutic Targeting of the Secreted Lysophospholipase D Autotaxin Suppresses Tuberous Sclerosis Complex-Associated TumorigenesisYou Feng, William J Mischler, Ashish C Gurung, et al.
The American Journal of Pathology|February 20, 2010
Establishment and genomic characterization of mouse xenografts of human primary prostate tumorsCarmen Priolo, Michelle Agostini, Natalie Vena, et al.
Oncotarget|May 13, 2017
Lysosomal regulation of cholesterol homeostasis in tuberous sclerosis complex is mediated via NPC1 and LDL-RHarilaos Filippakis, Nicola Alesi, Barbara Ogorek, et al.
Pageof 5